Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

STRIVE Post-Market Registry Study

NCT: NCT04302272 · RECRUITING

NCT IDNCT04302272
StatusRECRUITING
Start Date2021-10-09
SponsorOlympus Corporation of the Americas (INDUSTRY)
First posted
Last updated

Brief Summary

This is a single-arm, prospective, multi-center, Registry study to evaluate the long-term safety and effectiveness of the Spiration Valve System (SVS) for the treatment of severe emphysema in a post-market setting.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑